• Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Home
  • Insights & Articles
    • The Clinical Landscape: Strategic Insights into Retinal Care
      • The Modern Clinical Retina Landscape: A Strategic Overview
      • Surgical Approaches to Retinal Detachment: A Comparative Analysis
      • Gene Therapy in Retina: A Commercial and Clinical Appraisal
      • Evolving Treatment Paradigms for Diabetic Macular Edema
      • Analysis of the Anti-VEGF Market: From Revolution to Refinement
      • A Patient’s Guide to Understanding Age-Related Macular Degeneration (AMD)
    • The Business of Retina: Mastering Operations and Financial Health
      • Anatomy of a Retina Practice: A Strategic Guide to Financial Health and Operations
      • The Impact of Private Equity: Reshaping the Business of Retina
      • The Complete 2025 Guide to Ophthalmic J-Codes & Reimbursement
      • The Buy-and-Bill Model: A High-Risk, High-Reward Strategy
      • Staffing for Success: Key Roles in a High-Volume Retina Practice
      • Key Technology Investments for an Efficient Retina Clinic
      • Decoding CMS Reimbursement: A Guide to J-Codes and Revenue Cycle Management
    • The Innovation Pipeline: Shaping the Future of Retinal Care
      • Beyond the Needle: The Future of Drug Delivery in Retina
      • Heads-Up vs. Traditional: A Comparison of Surgical Visualization Platforms
      • How AI is Changing the Game in Retinal Disease Screening
      • The Rise of At-Home Monitoring for AMD
    • The Professional Ecosystem: Building a Career in Retina
      • A Day in the Life of a Retina Specialist: A Day of Preserving Sight
      • Industry vs. Academia: Choosing Your Career Path in Retina
      • The Role of Key Opinion Leaders (KOLs) in Retina
      • Maximizing Your ASRS Experience: A Fellow’s Guide
      • Navigating the Retina World: A Guide to Key Societies, Conferences, and Career Paths
  • Services
    • Search Engine Optimization (SEO) & Reputation Management
    • Content Marketing & Optometrist Network Development
    • Specialized Recruitment & Staffing Support
    • Professional Branding & Key Opinion Leader (KOL) Development
    • On-Demand Patient Education & Marketing Materials
    • Market Intelligence & M&A Consulting
  • Contact Us
    • Events
    • Subscribe
    • Submissions
Retina Consultant

Retina Consultant

Visionary News & Insightful Strategy

Retina Roundup Advertisement

Potential biomarkers of primary open-angle glaucoma in patient serum in Nigeria

April 23, 2025 by Retina News Feed Leave a Comment

Click here to view the original post by Ophthalmology Times.

In addition to our own original articles, the Retina Consultant team expertly curates relevant news and research from leading publications.to provide our readers with a comprehensive view of the retina & ophthalmology landscape, Full credit belongs to the original authors and publication. 

By clicking the link above, you will be leaving our site to view an article from its original source.


Sharpen your perspective. Get our weekly analysis of the news shaping the retina industry.

Please enable JavaScript in your browser to complete this form.
Loading


Researchers in Nigeria found a number of biomarkers in the serum analyses of patients with primary open-angle glaucoma (POAG) that they believe have “high potential” and should be investigated further.1 Abdulkabir Ayansiji Ayanniyi, MD, the first study author from the Departments of Ophthalmology, University of Abuja, and the University of Abuja Teaching Hospital, Gwagwalada, Abuja, Nigeria, shared the findings in International Ophthalmology.

A total of 235 adults who were ophthalmology patients were included; of these, 96 had been diagnosed with POAG and 139 did not. The mean patient ages with and without POAG were, respectively, 53.70 ± 13.15 years and 46.05±14.00 years (range, 18-85 years); 48.5% were men. All participants provided fasting blood samples and the samples were analyzed for urea and creatinine, electrolytes, enzymes, protein, bilirubin, and lipids, the researchers reported.

The investigators reported the following significant mean changes in the patients with POAG and the non-POAG patients, respectively: urea 37.04 ± 2.46 vs. 27.01 ± 1.00, P = 0.000; creatinine 1.08 ± 0.16 vs. 1.68 ± 0.15, P = 0.007; chloride 86.47 ± 2.91 vs. 78.63 ± 1.43, P = 0.017; alkaline phosphatase 17.47 ± 1.93 vs. 93.09 ± 13.87, P = 0.000; alanine aminotransferase 3.33 ± 0.61 vs. 14.95 ± 1.49, P = 0.000; total protein 5.60 ± 0.15 vs. 6.03 ± 0.09, P = 0.015; and globulin 2.34 ± 0.15 vs. 2.75 ± 0.09, P = 0.020.

The analyzed factors that did not reach significance were: sodium 140.16 ± 3.82 vs. 124.83 ± 3.17, P = 0.953; potassium 4.70 ± 0.19 vs. 4.67 ± 0.25, P = 0.29; aspartate aminotransferase 16.90 ± 1.57 vs. 21.37 ± 7.85, P = 0.258; albumin 3.26 ± 0.09 vs. 3.28 ± 0.05, P = 0.83; direct bilirubin 0.61 ± 0.04 vs. 0.57 ± 0.04, P = 0.32; total bilirubin 0.53 ± 0.06 vs. 0.90 ± 0.16, P = 0.14; cholesterol 169.39 ± 6.30 vs. 214.17 ± 4.60, P = 0.078; high density lipoprotein (HDL) 49.53 ± 2.58 vs. 45.11 ± 0.76, P = 0.104; and triglyceride 80.12 ± 4.79 vs. 91.44 ± 3.84, P = 0.271.

Ayanniyi and colleagues suggested that the significant serum parameters should be further investigated to determine their specificity as biomarkers for POAG.

Previous POAG research

In a previous study of POAG, lead co-authors Yaping Yang and Bo Qin, from the Department of Ophthalmology and Visual Science, Eye and Ear Nose Throat Hospital, Shanghai Medical College; the Key Laboratory of Myopia, Ministry of Health; and the Key Laboratory of Visual Impairment and Restoration, all in Fudan University, Shanghai, China, and colleagues also evaluated the serum lipid profiles of Chinese patients with POAG and assessed the disease correlation with the intraocular pressure (IOP). They compared the results to patients with primary angle-closure glaucoma (PACG).2

The study included 1,139, 1,248, and 356 Chinese individuals with, respectively, POAG, PACG, and controls. The lipids evaluated were HDL, low-density lipoproteins (LDL), triglycerides, cholesterol, and very low-density lipoproteins (VLDL). They also quantified the lipid levels of apolipoproteins A (APOA), B (APOB), E (APOE), and lipoprotein A (Lp(a)).

The authors reported that the patients with POAG had elevated serum levels of VLDL, APOA, and APOE but mitigated cholesterol levels compared with the control participants.

Significantly lower serum triglyceride, VLDL, and Lp(a) levels were seen in patients with PACG compared with the controls.

The authors also observed that the serum cholesterol (P = 0.019; β = -0.75, 95% confidence interval [CI]: -1.38 – -0.12) and HDL levels (P < 0.001; β = -2.91, 95% CI: -4.58 – -1.25) were inversely linked to IOP in patients with POAG, after adjusting for age, sex, and ocular metrics. In addition, serum Lp(a) levels were correlated with the average IOP (P = 0.023; β = -0.0039, 95% CI: -0.0073 – -0.006) and night peak (P = 0.027; β = -0.0061, 95% CI: -0.0113 – -0.0008) in patients with POAG.

“Significantly different serum lipid and lipoprotein profiles were observed in POAG and PACG patients. This study highlighted the differences in serum lipid and lipoprotein levels among Chinese POAG patients and their relationship with IOP and IOP fluctuation. Serum lipid and lipoprotein profiles should be considered while evaluating glaucoma risk,” the investigators concluded.

Further POAG study

In another POAG study, Mustafa Kalayci, MD, from the Department of Ophthalmology, Somalia Mogadishu – Turkey Education and Research Hospital, Mogadishu, Somalia, and the Department of Ophthalmology, Antalya Training and Research Hospital, University of Health Sciences, Antalya, Turkey, and colleagues, reported a high rate of development of POAG in Somalia in patients older than 40 years.3

Their prospective cross-sectional study included 1550 patients who were evaluated regarding age, gender, intraocular pressure, and optical cup/disk ratio, and central corneal thickness measurements.

The authors reported that the prevalence of glaucoma in the study population over 40 years of age was 7%.

Specifically, by decades of age they found that the prevalence rates increased with increasing age (P < 0.001): 40% in the 40- to 50-year group, 6.8% in the 50- to 60-year group, 7% in the 60- to 70-year group, 9.9% in the 70- to 80-year group, and 12.3% in the 80- to 90-year group.

The authors commented, “A high rate of POAG was seen in patients over 40 years of age in Somalia. The mechanism underlying POAG needs to be investigated in this population.”

References
  1. Ayanniyi AA, Mahmoud AO, JohnSam YO, et al. Survey of eye patients’ serum for biomarkers of primary open angle glaucoma in Gwagwalada, Nigeria: serum biomarkers for primary open angle glaucoma. Int Ophthalmol. 2025;45:151. https://doi.org/10.1007/s10792-025-03519-0
  2. Yang Y, Qin B, Ng TK, et al. Serum lipid and lipoprotein profiles and their association with intraocular pressure in primary open-angle glaucoma: an observational cross-sectional study in the Chinese population. Lipids Health Dis. 2024;23, 323. https://doi.org/10.1186/s12944-024-02316-5
  3. Kalayci M, Cetinkaya E, Erol MK. Prevalence of primary open-angle glaucoma in a Somalia population. Int Ophthalmol. 2021;41:581–586. https://doi.org/10.1007/s10792-020-01612-0

Filed Under: Ophthalmology Times

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

More to See

Bariatric Surgery May Outperform GLP-1 RAs in Longer-Term Weight Loss Benefits

December 12, 2025 By AAO News Feed

VIDEO: Ixo-vec gene therapy shows safe results throughout 4-year study period

December 12, 2025 By Healio Ophthalmology

Amniotic membrane superior to bandage contact after CXL

December 12, 2025 By Healio Ophthalmology

Chronic Kidney Disease as a Risk Factor for Age-related Macular Degeneration: Prospective Cohort and Mendelian Randomization Analyses

December 11, 2025 By Ophthalmology Science

Automated feature segmentation of ultra-widefield optical coherence tomography images

December 11, 2025 By Ophthalmology Science

Geographic Atrophy Structure-Function Relationships Based on Loss of OCT Outer Retinal Bands and Fundus Autofluorescence

December 11, 2025 By Ophthalmology Science

Senate rejects legislation to extend ACA subsidies

December 11, 2025 By Healio Ophthalmology

Global ophthalmology: Learning through teaching

December 11, 2025 By Healio Ophthalmology

GLP-1s may reduce risk for cataracts, dry AMD

December 11, 2025 By Healio Ophthalmology

AMA policy combats ‘deepfake doctors’

December 11, 2025 By Healio Ophthalmology

Footer

A RETINA-SPECIFIC ORGANIZATION

It’s clearly an advantage to work with a consulting group that’s focused on your industry. The team at Retina Consultant has over 50 years of retina-specific experience in healthcare business, practice management, marketing & operations.

We’ve got our eyes on working with the best retina groups and vendors in the industry.

See the best;  get in touch.

Recent News Posts

  • Surgeon volunteer opportunities available in US
  • Bariatric Surgery May Outperform GLP-1 RAs in Longer-Term Weight Loss Benefits
  • VIDEO: Ixo-vec gene therapy shows safe results throughout 4-year study period
  • Amniotic membrane superior to bandage contact after CXL
  • Chronic Kidney Disease as a Risk Factor for Age-related Macular Degeneration: Prospective Cohort and Mendelian Randomization Analyses

Search

Retina Consultant
Copyright © 2025